Glycan-mediated modification of the immune response.

about

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery.

P2860

Q39013095-3FD2C102-B0F5-444D-9E54-6E4D34E47977 Q50961166-160DCF0D-D485-4043-824B-817B42BC4794

P2860

Glycan-mediated modification of the immune response.

Item

http://www.wikidata.org/entity/Q40725344

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Glycan-mediated modification of the immune response.

@en

type

Item

label

Glycan-mediated modification of the immune response.

@en

prefLabel

Glycan-mediated modification of the immune response.

@en

P1476

Glycan-mediated modification of the immune response.

@en

P2093

Caroline B Madsen

http://www.w3.org/2001/XMLSchema#string

P2860

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.

Signalling through C-type lectin receptors: shaping immune responses.

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.

Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.

'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells.

Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses.

Seromic profiling of colorectal cancer patients with novel glycopeptide microarray

Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells

P304

e23659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.23659

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hans H Wandall

Anders Elm Pedersen

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237018420

http://www.w3.org/2001/XMLSchema#string

P698

23734320

http://www.w3.org/2001/XMLSchema#string

P932

3654590

http://www.w3.org/2001/XMLSchema#string

Glycan-mediated modification of the immune response.

about

P2860

P2860

Glycan-mediated modification of the immune response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932